From: Evaluation of IScore validity in a Greek cohort of patients with type 2 diabetes
Variable | Entire population | Diabetic patients (n=312) | Non diabetic patients (n=222) | p-value |
---|---|---|---|---|
iScore 30 days | 166,1 ± 56,3 | 185,3 ± 45,9 | 139,1 ± 58,7 | <0,05# |
iScore 1 year | 136,3 ± 41 | 149,1 ± 22,6 | 118,3 ± 43,6 | <0,05# |
Age (mean±SD) | 74,7 ± 6,6 | 75.03 ± 6.6 | 74.22 ± 6.5 | 0,222## |
74 (69 - 82) | 74 (69 - 80) | |||
Gender n (%) | 0,628* | |||
Female | 276 | 158 (50.6) | 118 (53.2) | |
Male | 258 | 154 (49.4) | 104 (46.8) | |
Stroke severity (CNS) n (%) | 0,247* | |||
0 | 21 | 13 (4.2) | 7 (3.2) | |
≤4 | 75 | 36 (11.5) | 39 (17.6) | |
5-7 | 204 | 123 (39.4) | 81 (36.5) | |
≥8 | 235 | 140 (44.9) | 95 (42.8) | |
Stroke subtype n (%) | <0,05* | |||
Lacunar origin | 244 | 168 (53.8) | 76 (34.2) | |
Nonlacunar origin | 219 | 102 (32.7) | 117 (52.7) | |
Undetermined origin | 71 | 42 (13.5) | 29 (13.1) | |
Risk factor n (%) | 0,304* | |||
Atrial fibrillation | 80 | 46 (14.7) | 34 (15.3) | |
CHF | 67 | 44 (14.1) | 23 (10.4) | |
Previous MI | 148 | 99 (31.7) | 49 (22.1) | |
Current smoker | 100 | 57 (18.3) | 43 (19.4) | |
Comorbid condition n (%) | 0,809** | |||
Cancer | 53 | 34 (10.9) | 19 (8.6) | |
Renal dialysis | 9 | 5 (1.6) | 4 (1.8) | |
Preadmission disability n (%) | 0,532* | |||
Independent | 435 | 254 (81.4) | 181 (81.5) | |
Dependent n | 99 | 58 (18.6) | 41 (18.5) | |
Glucose on admission, mmol/L,dL n (%) | <0,05* | |||
<7.5 (<135) | 295 | 159 (51) | 136 (61.3) | |
≥7.5 (≥135) | 239 | 153 (49) | 86 (38.7) | |
Mortality rate n (%) | 0,551* | |||
30 Day | 77 | 45 (14.4) | 32 (14.4) | |
1 Year | 141 | 86 (27.6) | 55 (24.8) | 0,268* |